Cahill Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
5,091
-91
-2% -$21.2K 0.13% 116
2025
Q4
$1.07M Buy
5,182
+1,074
+26% +$212K 0.12% 118
2025
Q3
$762K Buy
4,108
+792
+24% +$136K 0.09% 146
2025
Q2
$506K Buy
3,316
+7
+0.2% +$1.08K 0.06% 169
2025
Q1
$549K Sell
3,309
-51
-2% -$7.98K 0.07% 154
2024
Q4
$486K Sell
3,360
-678
-17% -$105K 0.07% 165
2024
Q3
$654K Buy
4,038
+459
+13% +$73.1K 0.09% 139
2024
Q2
$523K Sell
3,579
-210
-6% -$31.2K 0.07% 171
2024
Q1
$599K Buy
3,789
+288
+8% +$45.8K 0.08% 160
2023
Q4
$549K Buy
3,501
+23
+0.7% +$3.53K 0.08% 157
2023
Q3
$542K Sell
3,478
-107
-3% -$17.7K 0.09% 153
2023
Q2
$593K Sell
3,585
-189
-5% -$30.5K 0.1% 151
2023
Q1
$585K Buy
3,774
+274
+8% +$44.2K 0.1% 143
2022
Q4
$618K Sell
3,500
-1,796
-34% -$310K 0.12% 140
2022
Q3
$865K Buy
5,296
+1,022
+24% +$173K 0.18% 115
2022
Q2
$758K Buy
4,274
+52
+1% +$9.27K 0.16% 123
2022
Q1
$748K Buy
4,222
+25
+0.6% +$4.25K 0.14% 134
2021
Q4
$717K Sell
4,197
-947
-18% -$155K 0.14% 134
2021
Q3
$831K Buy
5,144
+83
+2% +$14.2K 0.17% 119
2021
Q2
$834K Buy
5,061
+295
+6% +$48.8K 0.19% 108
2021
Q1
$784K Buy
4,766
+1,402
+42% +$227K 0.19% 103
2020
Q4
$529K Buy
3,364
+280
+9% +$41.3K 0.13% 124
2020
Q3
$459K Buy
3,084
+50
+2% +$7.4K 0.17% 112
2020
Q2
$427K Sell
3,034
-13
-0.4% -$1.89K 0.17% 112
2020
Q1
$400K Buy
3,047
+171
+6% +$24.3K 0.19% 103
2019
Q4
$420K Sell
2,876
-201
-7% -$27.3K 0.15% 119
2019
Q3
$399K Sell
3,077
-3,094
-50% -$408K 0.16% 115
2019
Q2
$860K Sell
6,171
-496
-7% -$68.7K 0.34% 75
2019
Q1
$932K Sell
6,667
-221
-3% -$29.6K 0.39% 68
2018
Q4
$889K Sell
6,888
-484
-7% -$67.5K 0.44% 61
2018
Q3
$1.02M Sell
7,372
-253
-3% -$33.6K 0.45% 59
2018
Q2
$926K Buy
7,625
+891
+13% +$111K 0.43% 62
2018
Q1
$863K Buy
6,734
+418
+7% +$56.5K 0.41% 61
2017
Q4
$883K Sell
6,316
-5
-0.1% -$696 0.44% 58
2017
Q3
$822K Sell
6,321
-60
-0.9% -$7.95K 0.43% 58
2017
Q2
$845K Buy
6,381
+3
+0% +$383 0.47% 53
2017
Q1
$795K Sell
6,378
-182
-3% -$21.7K 0.46% 53
2016
Q4
$756K Buy
6,560
+3
+0% +$347 0.46% 54
2016
Q3
$775K Buy
6,557
+452
+7% +$54.8K 0.5% 47
2016
Q2
$741K Sell
6,105
-243
-4% -$27.6K 0.52% 50
2016
Q1
$687K Buy
6,348
+133
+2% +$13.8K 0.51% 48
2015
Q4
$639K Sell
6,215
-344
-5% -$34.6K 0.52% 49
2015
Q3
$613K Sell
6,559
-767
-10% -$74.2K 0.5% 53
2015
Q2
$714K Sell
7,326
-560
-7% -$56.1K 0.53% 48
2015
Q1
$794K Sell
7,886
-895
-10% -$91K 0.6% 45
2014
Q4
$919K Sell
8,781
-245
-3% -$25.8K 0.71% 40
2014
Q3
$963K Buy
9,026
+105
+1% +$10.9K 0.77% 38
2014
Q2
$934K Buy
8,921
+764
+9% +$77.2K 0.73% 40
2014
Q1
$802K Sell
8,157
-27
-0.3% -$2.5K 0.69% 40
2013
Q4
$750K Buy
+8,184
New +$754K 0.65% 42

Other funds holding JNJ

Cahill Financial Advisors's JNJ Position: Q1 2026 in Review

Cahill Financial Advisors reduced its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2026, selling an estimated $21.2K and leaving 5,091 shares worth $1.24M. The position accounts for 0.13% of the portfolio, ranked #116.

Cahill Financial Advisors first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cahill Financial Advisors held 5,091 shares of Johnson & Johnson worth $1.24M as of Q1 2026.
  • Cahill Financial Advisors sold 91 Johnson & Johnson shares in Q1 2026, an estimated $21.2K.
  • Johnson & Johnson made up 0.13% of Cahill Financial Advisors's portfolio in Q1 2026, its #116 holding.
  • Cahill Financial Advisors first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cahill Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.